Lite Strategy, Inc. (LITS)
1.04
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
Lite Strategy Cash from Investing (Quarterly) : 2.098M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.098M |
| December 31, 2025 | 0.569M |
| September 30, 2025 | -100.00M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 20.45M |
| September 30, 2024 | 14.70M |
| June 30, 2024 | 19.54M |
| March 31, 2024 | 0.122M |
| December 31, 2023 | 24.52M |
| September 30, 2023 | 4.957M |
| June 30, 2023 | 19.40M |
| March 31, 2023 | 10.02M |
| December 31, 2022 | 10.53M |
| September 30, 2022 | 13.74M |
| June 30, 2022 | 20.11M |
| March 31, 2022 | 15.16M |
| December 31, 2021 | -43.37M |
| September 30, 2021 | 14.99M |
| June 30, 2021 | 9.988M |
| March 31, 2021 | 15.39M |
| December 31, 2020 | -5.144M |
| September 30, 2020 | 4.476M |
| June 30, 2020 | -85.05M |
| March 31, 2020 | 9.103M |
| Date | Value |
|---|---|
| December 31, 2019 | -35.32M |
| September 30, 2019 | 4.967M |
| June 30, 2019 | 9.955M |
| March 31, 2019 | 9.768M |
| December 31, 2018 | -0.193M |
| September 30, 2018 | 4.788M |
| June 30, 2018 | -59.43M |
| March 31, 2018 | 5.098M |
| December 31, 2017 | 4.963M |
| September 30, 2017 | 5.042M |
| June 30, 2017 | -0.04M |
| March 31, 2017 | -5.012M |
| December 31, 2016 | 5.008M |
| September 30, 2016 | -10.03M |
| June 30, 2016 | 0.029M |
| March 31, 2016 | 5.002M |
| December 31, 2015 | 0.026M |
| September 30, 2015 | 4.915M |
| June 30, 2015 | 4.999M |
| March 31, 2015 | 4.99M |
| December 31, 2014 | -30.04M |
| September 30, 2014 | 9.995M |
| June 30, 2014 | -0.038M |
| March 31, 2014 | -15.02M |
| December 31, 2013 | -20.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.52M |
| Cash from Financing (Quarterly) | -1.792M |
| Free Cash Flow | -110.42M |
| Free Cash Flow Per Share (Quarterly) | -2.843 |
| Free Cash Flow to Equity (Quarterly) | -101.52M |
| Free Cash Flow to Firm (Quarterly) | -101.52M |
| Free Cash Flow Yield | -388.8% |